Esmolol
Supraventricular tachycardia or noncompensatory sinus tachycardia, Intraoperative and postoperative tachycardia and/or hypertension
High-alert medication
- Adrenergic antagonists, IV (class)
Indications
- Supraventricular tachycardia or noncompensatory sinus tachycardia
- Intraoperative and postoperative tachycardia and/or hypertension
Adult dosing
- svt maintenance: dose: 50; unit: mcg/kg/min; route: IV; interval: 50 to 200 mcg/kg/min; weightBased: true; maxDose: 200; titrationTarget: Titrate to effect using ventricular rate or blood pressure at ≥4-minute intervals; labelExcerpt: The effective maintenance dose for continuous and step-wise dosing is 50 to 200 mcg per kg per minute, although doses as low as 25 mcg per kg per minute have been adequate.
- perioperative immediate: dose: 1; unit: mg/kg; route: IV; interval: 1 mg/kg bolus over 30 seconds followed by 150 mcg/kg/min infusion; weightBased: true; titrationTarget: Titrate to effect using ventricular rate or blood pressure at ≥4-minute intervals; labelExcerpt: Administer 1 mg per kg as a bolus dose over 30 seconds followed by an infusion of 150 mcg per kg per min if necessary.
- perioperative gradual: dose: 500; unit: mcg/kg; route: IV; interval: 500 mcg/kg bolus over 1 min then 50 mcg/kg/min for 4 min; weightBased: true; titrationTarget: Titrate to effect using ventricular rate or blood pressure at ≥4-minute intervals; labelExcerpt: Administer 500 mcg per kg as a bolus dose over 1 minute followed by a maintenance infusion of 50 mcg per kg per min for 4 minutes.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- No dosage adjustment necessary.
Contraindications
- Severe sinus bradycardia
- Heart block greater than first degree
- Sick sinus syndrome
- Decompensated heart failure
- Cardiogenic shock
Clinical pearls
- Requires titration to desired heart rate/blood pressure at ≥4-minute intervals.
- Do not exceed 200 mcg/kg/min for SVT; max 300 mcg/kg/min for hypertension.
- Avoid extravasation as severe infusion site reactions including necrosis may occur.
- Monitor for hypotension and bradycardia; effects typically reverse within 30 minutes of discontinuation.
Source and review
- DailyMed label (esmolol hydrochloride), Set ID 519cc19c-e2b6-4984-bfad-45276d4cf0e6, effective 2026-10-28. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties